Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

CCL19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cells.

Jørgensen AS, Adogamhe PE, Laufer JM, Legler DF, Veldkamp CT, Rosenkilde MM, Hjortø GM.

J Leukoc Biol. 2018 Aug;104(2):401-411. doi: 10.1002/JLB.2VMA0118-008R. Epub 2018 May 16.

PMID:
29768676
2.

Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands.

Moussouras NA, Getschman AE, Lackner ER, Veldkamp CT, Dwinell MB, Volkman BF.

Int J Mol Sci. 2017 Sep 3;18(9). pii: E1894. doi: 10.3390/ijms18091894.

3.

CCR7 Sulfotyrosine Enhances CCL21 Binding.

Phillips AJ, Taleski D, Koplinski CA, Getschman AE, Moussouras NA, Richard AM, Peterson FC, Dwinell MB, Volkman BF, Payne RJ, Veldkamp CT.

Int J Mol Sci. 2017 Aug 25;18(9). pii: E1857. doi: 10.3390/ijms18091857.

4.

Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation.

Ziarek JJ, Kleist AB, London N, Raveh B, Montpas N, Bonneterre J, St-Onge G, DiCosmo-Ponticello CJ, Koplinski CA, Roy I, Stephens B, Thelen S, Veldkamp CT, Coffman FD, Cohen MC, Dwinell MB, Thelen M, Peterson FC, Heveker N, Volkman BF.

Sci Signal. 2017 Mar 21;10(471). pii: eaah5756. doi: 10.1126/scisignal.aah5756.

5.

Crystallographic Structure of Truncated CCL21 and the Putative Sulfotyrosine-Binding Site.

Smith EW, Lewandowski EM, Moussouras NA, Kroeck KG, Volkman BF, Veldkamp CT, Chen Y.

Biochemistry. 2016 Oct 11;55(40):5746-5753. Epub 2016 Sep 26.

6.

Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin binding.

Barmore AJ, Castex SM, Gouletas BA, Griffith AJ, Metz SW, Muelder NG, Populin MJ, Sackett DM, Schuster AM, Veldkamp CT.

Biochem Biophys Res Commun. 2016 Sep 2;477(4):602-606. doi: 10.1016/j.bbrc.2016.06.098. Epub 2016 Jun 21.

7.

Production of Recombinant Chemokines and Validation of Refolding.

Veldkamp CT, Koplinski CA, Jensen DR, Peterson FC, Smits KM, Smith BL, Johnson SK, Lettieri C, Buchholz WG, Solheim JC, Volkman BF.

Methods Enzymol. 2016;570:539-65. doi: 10.1016/bs.mie.2015.09.031. Epub 2015 Nov 14.

8.

Preparation and Analysis of N-Terminal Chemokine Receptor Sulfopeptides Using Tyrosylprotein Sulfotransferase Enzymes.

Seibert C, Sanfiz A, Sakmar TP, Veldkamp CT.

Methods Enzymol. 2016;570:357-88. doi: 10.1016/bs.mie.2015.09.004. Epub 2015 Nov 14.

9.

Polysialylation controls dendritic cell trafficking by regulating chemokine recognition.

Kiermaier E, Moussion C, Veldkamp CT, Gerardy-Schahn R, de Vries I, Williams LG, Chaffee GR, Phillips AJ, Freiberger F, Imre R, Taleski D, Payne RJ, Braun A, Förster R, Mechtler K, Mühlenhoff M, Volkman BF, Sixt M.

Science. 2016 Jan 8;351(6269):186-90. doi: 10.1126/science.aad0512. Epub 2015 Dec 10.

10.

Solution Structure of CCL19 and Identification of Overlapping CCR7 and PSGL-1 Binding Sites.

Veldkamp CT, Kiermaier E, Gabel-Eissens SJ, Gillitzer ML, Lippner DR, DiSilvio FA, Mueller CJ, Wantuch PL, Chaffee GR, Famiglietti MW, Zgoba DM, Bailey AA, Bah Y, Engebretson SJ, Graupner DR, Lackner ER, LaRosa VD, Medeiros T, Olson ML, Phillips AJ, Pyles H, Richard AM, Schoeller SJ, Touzeau B, Williams LG, Sixt M, Peterson FC.

Biochemistry. 2015 Jul 14;54(27):4163-6. doi: 10.1021/acs.biochem.5b00560. Epub 2015 Jul 6.

11.

The solution structure of the forkhead box-O DNA binding domain of Brugia malayi DAF-16a.

Casper SK, Schoeller SJ, Zgoba DM, Phillips AJ, Morien TJ, Chaffee GR, Sackett PC, Peterson FC, Crossgrove K, Veldkamp CT.

Proteins. 2014 Dec;82(12):3490-6. doi: 10.1002/prot.24701. Epub 2014 Oct 21.

12.

Chemokines in colitis: microRNA control.

Roy I, Veldkamp CT, Volkman BF, Dwinell MB.

Gut. 2014 Aug;63(8):1202-4. doi: 10.1136/gutjnl-2013-305886. Epub 2013 Oct 18. No abstract available.

13.

Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus.

Ziarek JJ, Veldkamp CT, Zhang F, Murray NJ, Kartz GA, Liang X, Su J, Baker JE, Linhardt RJ, Volkman BF.

J Biol Chem. 2013 Jan 4;288(1):737-46. doi: 10.1074/jbc.M112.394064. Epub 2012 Nov 12.

14.

Solution structure of the cold-shock-like protein from Rickettsia rickettsii.

Gerarden KP, Fuchs AM, Koch JM, Mueller MM, Graupner DR, O'Rorke JT, Frost CD, Heinen HA, Lackner ER, Schoeller SJ, House PG, Peterson FC, Veldkamp CT.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Nov 1;68(Pt 11):1284-8. doi: 10.1107/S174430911203881X. Epub 2012 Oct 26.

15.

Solution structure of CCL21 and identification of a putative CCR7 binding site.

Love M, Sandberg JL, Ziarek JJ, Gerarden KP, Rode RR, Jensen DR, McCaslin DR, Peterson FC, Veldkamp CT.

Biochemistry. 2012 Jan 24;51(3):733-5. doi: 10.1021/bi201601k. Epub 2012 Jan 17.

16.

Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways.

Drury LJ, Ziarek JJ, Gravel S, Veldkamp CT, Takekoshi T, Hwang ST, Heveker N, Volkman BF, Dwinell MB.

Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17655-60. doi: 10.1073/pnas.1101133108. Epub 2011 Oct 11.

17.

Sulfotyrosine recognition as marker for druggable sites in the extracellular space.

Ziarek JJ, Heroux MS, Veldkamp CT, Peterson FC, Volkman BF.

Int J Mol Sci. 2011;12(6):3740-56. doi: 10.3390/ijms12063740. Epub 2011 Jun 8.

18.

Targeting SDF-1/CXCL12 with a ligand that prevents activation of CXCR4 through structure-based drug design.

Veldkamp CT, Ziarek JJ, Peterson FC, Chen Y, Volkman BF.

J Am Chem Soc. 2010 Jun 2;132(21):7242-3. doi: 10.1021/ja1002263.

19.

Monomeric structure of the cardioprotective chemokine SDF-1/CXCL12.

Veldkamp CT, Ziarek JJ, Su J, Basnet H, Lennertz R, Weiner JJ, Peterson FC, Baker JE, Volkman BF.

Protein Sci. 2009 Jul;18(7):1359-69. doi: 10.1002/pro.167.

20.

Sequential tyrosine sulfation of CXCR4 by tyrosylprotein sulfotransferases.

Seibert C, Veldkamp CT, Peterson FC, Chait BT, Volkman BF, Sakmar TP.

Biochemistry. 2008 Oct 28;47(43):11251-62. doi: 10.1021/bi800965m. Epub 2008 Oct 4.

21.

Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12.

Veldkamp CT, Seibert C, Peterson FC, De la Cruz NB, Haugner JC 3rd, Basnet H, Sakmar TP, Volkman BF.

Sci Signal. 2008 Sep 16;1(37):ra4. doi: 10.1126/scisignal.1160755.

22.

On-column refolding of recombinant chemokines for NMR studies and biological assays.

Veldkamp CT, Peterson FC, Hayes PL, Mattmiller JE, Haugner JC 3rd, de la Cruz N, Volkman BF.

Protein Expr Purif. 2007 Mar;52(1):202-9. Epub 2006 Sep 24.

23.

Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12).

Veldkamp CT, Seibert C, Peterson FC, Sakmar TP, Volkman BF.

J Mol Biol. 2006 Jun 23;359(5):1400-9. Epub 2006 May 11.

24.

The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin.

Veldkamp CT, Peterson FC, Pelzek AJ, Volkman BF.

Protein Sci. 2005 Apr;14(4):1071-81. Epub 2005 Mar 1.

Supplemental Content

Loading ...
Support Center